Patent · US Active

C-3 and C-17 modified triterpenoids as HIV-1 inhibitors

US11084845B2 · kind B2 · utility

0Cited by
3References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 7, 2019
Grant dateAug 10, 2021
Priority date—
Expiry dateAug 7, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2740/16222
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Compounds having drug and bio-affecting properties, their pharmaceutical compositions and methods of use are set forth. In particular, betulinic acid derivatives that possess unique antiviral activity are provided as HIV maturation inhibitors, as represented by compounds of Formula I: These compounds are useful for the treatment of HIV and AIDS.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.